Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
clinical trials
4
×
life sciences
national blog main
alexion pharmaceuticals
boston
boston blog main
boston top stories
deals
boehringer ingelheim
fda
hepatitis b
national top stories
rna interference
alnylam
alnylam pharmaceutials
alnylam pharmaceuticals
amyotrophic lateral sclerosis (als)
arena pharmaceuticals
arrowhead pharmaceuticals
artie suckow
autoimmune disorders
complement system
dicerna pharamceuticals
dicerna pharmaceuticals
drug delivery
dtx pharma
eli lilly
financing
generalized myasthenia gravis
hepatitis b virus
hereditary transthyretin amyloidosis
immune-mediated necrotizing myopathy
indiana blog main
indiana top stories
jeff friedman
john grundy
johnson & johnson
neurodegenerative diseases
patisiran
What
medicines
4
×
pharma
4
×
deal
dicerna
disease
drug
pharmaceuticals
rna
small
abandoning
advance
ago
alternative
autoimmune
baggage
biologics
candidate
caught
causing
companies
considered
cuts
deliver
development
diseases
drugs
dtx
expensive
eye
free
gene
gets
hepatitis
hitting
intended
interference
lead
long
molecules
new
Language
unset
Current search:
medicines
×
biotech
×
pharma
×
" clinical trials "
×
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M